Publication | Closed Access
In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma
36
Citations
40
References
2015
Year
Our results provide evidence that the PPAR-γ agonist rosiglitazone may have potential in the development of therapies for bronchial asthma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1